lisinoplus 10+12,5 mg tabletter
stada arzneimittel ag - hydrochlorthiazid, lisinoprildihydrat - tabletter - 10+12,5 mg
lisinoplus 20+12,5 mg tabletter
stada arzneimittel ag - hydrochlorthiazid, lisinoprildihydrat - tabletter - 20+12,5 mg
ramipril/hydrochlorthiazid "ratiopharm" 5+25 mg tabletter
ratiopharm gmbh - hydrochlorthiazid, ramipril - tabletter - 5+25 mg
ramipril "ratiopharm" 10 mg tabletter
ratiopharm gmbh - ramipril - tabletter - 10 mg
ramipril "ratiopharm" 2,5 mg tabletter
ratiopharm gmbh - ramipril - tabletter - 2,5 mg
ramipril "ratiopharm" 5 mg tabletter
ratiopharm gmbh - ramipril - tabletter - 5 mg
trandolapril "aurobindo" 0,5 mg kapsler, hårde
aurobindo pharma (malta) limited - trandolapril - kapsler, hårde - 0,5 mg
trandolapril "aurobindo" 2 mg kapsler, hårde
aurobindo pharma (malta) limited - trandolapril - kapsler, hårde - 2 mg
kantor flydende middel
agroplanta gmbh & co. kg - additiv - flydende middel - 1000 g/l additiv
zejula
glaxosmithkline (ireland) limited - niraparib (tosilate monohydrate) - fallopian tube neoplasms; peritoneal neoplasms; ovarian neoplasms - antineoplastiske midler - zejula is indicated: , as monotherapy for the maintenance treatment of adult patients with advanced epithelial (figo stages iii and iv) high-grade ovarian, fallopian tube or primary peritoneal cancer who are in response (complete or partial) following completion of first-line platinum-based chemotherapy. , as monotherapy for the maintenance treatment of adult patients with platinum sensitive relapsed high grade serous epithelial ovarian, fallopian tube, or primary peritoneal cancer who are in response (complete or partial) to platinum based chemotherapy.